Therapy management techniques for an implantable medical device

• US 7,415,384 B2
• Filed: 03/09/2006
• Issued: 08/19/2008
• Est. Priority Date: 12/29/2000
• Status: Expired due to Term

• Current Assignee: Jerome T. Hartlaub
• Original Assignee: Jerome T. Hartlaub
• Inventors: Hartlaub, Jerome T.
• Primary Examiner(s): Lau; Tung S
• Application Number:
  US11/372,364
• Publication Number:
  US 20060265140A1
• Time in Patent Office: 894 Days
• Field of Search: 702/182
• US Class Current: 702/182
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2205/3523 using telemetric means
• CPC Class Codes: A61M 2205/3561 local, e.g. within room or hospital
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/67 for remote operation

Abstract

Disclosed is a method and apparatus for automatically adjusting drug infusion rate to optimize treatment therapy. The implantable medical device can communicate with a database or algorithm controlled by a caregiver or physician. Thus, the caregiver may request a therapy change (e.g., infusion rate versus time, pump clock settings, etc.) or a therapy management module may automatically activate the therapy change at some future time for convenience, or for technical or clinical reasons.

Claims

1. An implantable drug delivery system having a data delivery feature, comprising:

an external device;

a housing;

a drug reservoir positioned in the housing and configured to contain a therapeutic substance;

an infusion port in fluid communication with the drug reservoir;

a pump configured to direct the therapeutic substance from the drug reservoir to the infusion port; and

electronics coupled to pump and configured to control the flow of therapeutic substances from the drug reservoir to the infusion port, the electronics including a memory configured to store performance information and programming, the electronics further configured to monitor the flow of the therapeutic substance, wherein the electronics is configured to be in bi-directional communication with the external device and to provide performance information from the memory to the external device and to receive changes to the programming in the memory from the external device.

2. The implantable drug delivery system of claim 1, further comprising a sensor configured to provide feedback to the electronics.

3. The implantable drug delivery system of claim 1, wherein the external device is configured to be coupled via a network to at least one entity selected from a group consisting of an insurance provider, a pharmacy, a hospital, a caregiver, a physician and a device manufacture.

4. The implantable drug delivery system of claim 1, wherein the external device comprises a data-acquisition device.

5. The implantable drug delivery system of claim 1, further comprising a catheter with a distal end extending from the housing, wherein catheter is fluidly coupled to the drug reservoir and the distal end is coupled to the infusion port.

6. The implantable drug delivery system of claim 1, wherein the pump is positioned in the housing.

7. The implantable drug delivery system of claim 1, further comprising a pump reservoir sensor.

8. The implantable drug delivery system of claim 1, wherein the external device is in communication with a database, the database including algorithms for modifying the programming of the electronics based on performance data provided to the external device.

9. The implantable drug delivery system of claim 2, wherein the electronics is configured to modify the flow of the therapeutic substance in response to the feedback and the programming in the memory.

10. The implantable drug system of claim 3, wherein the network includes a connection over an Internet.

11. The implantable drug delivery system of claim 3, wherein the network includes a connection over a land-based line.

12. An implantable drug delivery device, comprising:

a housing;

a drug reservoir positioned in the housing and configured to contain a therapeutic substance;

an infusion port in fluid communication with the drug reservoir;

a pump in the housing, the pump configured to direct the therapeutic substance from the drug reservoir to the infusion port;

electronics coupled to the pump and configured to control the flow of therapeutic substances from the drug reservoir to the infusion port, the electronics including a memory configured to store performance information and programming, the electronics further configured to monitor the flow of the therapeutic substance and to communicate with an external programmer via a network so that performance information of the implanted drug delivery device can be reported and programming on the device can be modified based on the performance information; and

a sensor configured to in provide feedback to the electronics;

wherein the electronics is configured to accept programming via telemetry so as to control whether the therapeutic substance is delivered through the infusion port based on the feedback received from the sensor.

13. The implantable drug delivery system of claim 12, wherein the network is an Internet.

14. The implantable drug delivery system of claim 12, wherein the network includes a connection over a land-based line.

15. The implantable drug delivery system of claim 12, wherein external programmer comprises a database.

16. The implantable drug delivery system of claim 15, further comprising a pump reservoir sensor.

17. An implantable drug delivery device, comprising:

a housing;

a drug reservoir positioned in the housing and configured to contain a therapeutic substance;

an infusion port in fluid communication with the drug reservoir;

a pump configured to direct the therapeutic substance from the drug reservoir to the infusion port;

a microprocessor positioned in the housing and configured to control the pump, the microprocessor including a memory configured to store performance information and programming, the microprocessor further configured to monitor the flow of the therapeutic substance and to use bi-directional communication with an external programmer so that performance information of the implanted drug delivery device can be reported and programming on the device can be modified based on the performance information.

18. The implantable drug delivery system of claim 17, wherein the microprocessor is configured to communication with the external programmer via an Internet connection.

19. The implantable drug delivery system of claim 17, further comprising a sensor configured to sense characteristics of a patient, wherein the microprocessor is configured to receive signals received from the sensor and store them in the memory.

20. The implantable drug delivery system of claim 19, wherein the microprocessor is configured to determine whether a therapy change is needed based on the signals received from the sensor.